[HONG KONG, August 20, 2021] Recently, the 2021 Merck Greater Bay Area Innovation Bootcamp was held in Guangzhou. After comprehensive consideration and careful evaluation by Merck China and global experts from multiple dimensions such as technical foresight and market potential, 15 projects were finally ed from 430 projects around the world. GBB stood out and was ed as one of the final entry projects.

The Merck Greater Bay Area Innovation Bootcamp is an innovation project sponsored by Merck Guangdong Innovation Hub and co-sponsored by Miracle Light Life Science Accelerator. Based in the Greater Bay Area and facing the world, it aims to link Merck China and global business resources for life sciences start-up projects, explores cooperation opportunities and innovation models, and creates more value for the innovation ecology of Greater Bay Area.

Dr. Michael Chen, Co-founder and CEO of GBB, said: "I'm glad to have this opportunity to participate in the 2021 Merck Greater Bay Innovation Bootcamp. With the rich resources and technical advantages of this bootcamp and Greater Bay Area, we explored the cooperation and innovation mode with a number of excellent enterprises, which promoted the innovation and development of biotechnology. In the future, GBB will continue to take innovation driven R&D as its core competitiveness and build AI-enabled bioprocessing development platforms to make global bioprocessing development simpler and more efficient. "

About Merck Innovation Hub

Merck China Innovation Hub is an important part of Merck's global innovation network. It is committed to searching, incubating and investing in innovation opportunities between and outside medical and health, life sciences, electronic technologyand existing business areas. Merck China Innovation hub is rooted in China's innovation ecology, actively establishes partnership with start-ups, academic institutions, industry partners and local governments, integrates the unique technologies and professional skills of Merck group and partners in their respective related fields, develops innovative technologies, brings new solutions to the Chinese market and global business, and provides opportunities for local innovative talents Partners and Merck employees provide creative stimulation, training and innovation incubation support to achieve win-win cooperation. For more information about Merck China Innovation hub, please visit innovationchina.merckgroup.com.

About GBB

Headquartered in Hong Kong, Great Bay Bio (GBB) is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to biopharmaceutical development and other blue oceanbio-products, ultimately solving numerous pain points of biopharmaceutical industry, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has obtained massive data from conventional biologics development in its 3100 m² CMC facilities which bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created the intelligent centralized database, where deep learning is being performed to create next generation of AI-enabled bioprocessing ecosystem. To learn more, please visit http://www.greatbay-bio.com.